Lisa DeFrancesco

Lisa DeFrancesco

Investor Relations Contact at LEXICON PHARMACEUTICALS, INC.

Net worth: 211 205 $ as of 2026-08-30

47 year
Health Technology
Finance
Communications

Profile

Lisa M.
DeFrancesco
currently works at Lexicon Pharmaceuticals, Inc., as SVP-Investor Relations & Corporate Communications from 2023 and National Investor Relations Institute, as Member.
Ms. DeFrancesco also formerly worked at Avis Budget Group, Inc., as Principal, Actavis, Inc., as Vice President-Global Investor Relations from 2009 to 2014, Anywhere Real Estate Group LLC, as Principal, Intercept Pharmaceuticals, Inc., as Senior Vice President-Corporate Affairs from 2021 to 2022, Virgin Mobile USA, Inc., as Principal, Amarin Corp.
Plc, as Senior VP-Investor Relations & Corporate Affairs from 2022 to 2023, Horizon Healthcare Services, Inc., as Principal, Allergan UC, as Head-Investor Relations, and Melinta Therapeutics, Inc., as SVP-Corporate Communications & Government Affairs from 2017 to 2020.
Ms. DeFrancesco received her undergraduate degree from Stillman School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-27 93,869 ( 0.02% ) 211 205 $ 2026-08-30

Lisa DeFrancesco active positions

CompaniesPositionStart
LEXICON PHARMACEUTICALS, INC. Investor Relations Contact 2023-11-12
Corporate Officer/Principal -

Former positions of Lisa DeFrancesco

CompaniesPositionEnd
AMARIN CORPORATION PLC Investor Relations Contact 2023-07-31
INTERCEPT PHARMACEUTICALS, INC. Investor Relations Contact 2022-01-27
MELINTA THERAPEUTICS, INC. Investor Relations Contact 2020-11-30
ALLERGAN PLC Investor Relations Contact 2017-02-27
Investor Relations Contact 2014-04-23
See the detail of Lisa DeFrancesco's experience

Training of Lisa DeFrancesco

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Communications

Health Services

Commercial Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Lisa DeFrancesco